Author: KCCure

KCCure urges Congress and CMS to Reconsider Misguided Medicare Changes

KCCure joins 239 advocacy organizations asking Congress and CMS to reconsider changes allowing Medicare Advantage plans to implement a new policy that could negatively impact Medicare patients with kidney cancer.

Deadline Extension for Federal Kidney Cancer Research Program

This is to notify the research community of the recently extended deadline for the Fiscal Year 2018 (FY18) funding opportunities for the Department of Defense (DOD) Kidney Cancer Research Program (KCRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP).  

11th Annual Dana Farber/Harvard Cancer Center Kidney Cancer Symposium

On September 7th, the Harvard Medical Research Centers including Dana Farber, Beth Isreal, Brigham & Women's will once again hold their annual Kidney Cancer Symposium at the Newton Massachessetts Marriott. The Symposium is an all-day in-person and virtual event beginning at 8:00 a.m. and concluding at 3:30 pm. 

Voice of Kidney Cancer – Barbara Muchow

Barbara Muchow is a kidney cancer survivor. She shares a beautiful story of friendship and loss and how it led to an early diagnosis of kidney cancer. To tell my cancer story I have to tell about my best friend of 40 years, Dorothy. Actually, Dorothy, her husband Bob and my husband and I were all best friends. We first met in Illinois as young parents and ended up in Nevada as retirees. Dorothy an...

Alison Brooke McDonough – In Memoriam

KCCure tribute to Alison McDonough who bravely battle papillary RCC.

We Hit our Goal! $50,000 in new Research Funding for Kidney Cancer

KCCure hits goal of raising $50,000 in new kidney cancer research funding. Learn more about our Kidney Cancer Research Grant Program and our mission for find a cure for kidney cancer.

Joe Paterniti – In Memoriam

KCCure tribute to Joe Paterniti (1969-2017) a dedicated father and husband who lost his life to kidney cancer.

KCCure Urges EMA to approve Opdivo/Yervoy for European Kidney Cancer Patients

July 30, 2018 Washington, DC, – The Kidney Cancer Research Alliance(KCCure) responded to the Committee for Medicinal Products for Human Use (CHMP) recommendation against approval by the European Medicines Agency (EMA) of ipilimumab (Yervoy) combined with nivolumab (Opdivo) for the first line treatment of high and intermediate risk metastatic renal cell carcinoma (kidney cancer). The question of si...

Voice of Kidney Cancer – Katherine Battle

Katherine Battle was nine when her dad died of kidney cancer.  In this essay she writes about loss, remembrance and above all things - enduring love.  The past can't be changed - but her voice gives us all hope for the future.

Voice of Kidney Cancer – James

"I realize that there is no avoiding death from this disease, so I plan for its eventuality but I refuse to stop living. Cancer does not define me." James is a stage 4 kidney cancer survivor and this is is his story.

Voice of Kidney Cancer – Julie Shill

Julie is a stage 4 kidney cancer survivor and author of the blog: Julie's Not Dying Today. Her latest post about working with Sonya Owens, a Licensed Clinical Social Worker on managing emotional aspects of cancer is something that all patients can benefit from. Thank you Julie for educating and inspiring!

What is No Tie July?

When it comes to kidney cancer, a tie isn’t good enough. We need a win. Join our month-long fundraising effort, No Tie July, and help us raise one year of life-saving research funding in just one month.

Lost Password

Register

Subscribe for updates!